Caseware UK (AP4) 2024.0.164 2024.0.164 2025-07-31 2025-07-31 2024-08-01 false No description of principal activity 1 1 false true The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 07426348 2024-08-01 2025-07-31 07426348 2023-08-01 2024-07-31 07426348 2025-07-31 07426348 2024-07-31 07426348 c:Director1 2024-08-01 2025-07-31 07426348 d:FurnitureFittings 2024-08-01 2025-07-31 07426348 d:FurnitureFittings 2025-07-31 07426348 d:FurnitureFittings 2024-07-31 07426348 d:FurnitureFittings d:OwnedOrFreeholdAssets 2024-08-01 2025-07-31 07426348 d:CurrentFinancialInstruments 2025-07-31 07426348 d:CurrentFinancialInstruments 2024-07-31 07426348 d:Non-currentFinancialInstruments 2025-07-31 07426348 d:Non-currentFinancialInstruments 2024-07-31 07426348 d:CurrentFinancialInstruments d:WithinOneYear 2025-07-31 07426348 d:CurrentFinancialInstruments d:WithinOneYear 2024-07-31 07426348 d:Non-currentFinancialInstruments d:AfterOneYear 2025-07-31 07426348 d:Non-currentFinancialInstruments d:AfterOneYear 2024-07-31 07426348 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2025-07-31 07426348 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2024-07-31 07426348 d:ShareCapital 2025-07-31 07426348 d:ShareCapital 2024-07-31 07426348 d:RetainedEarningsAccumulatedLosses 2025-07-31 07426348 d:RetainedEarningsAccumulatedLosses 2024-07-31 07426348 c:FRS102 2024-08-01 2025-07-31 07426348 c:AuditExempt-NoAccountantsReport 2024-08-01 2025-07-31 07426348 c:FullAccounts 2024-08-01 2025-07-31 07426348 c:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 07426348 2 2024-08-01 2025-07-31 07426348 e:PoundSterling 2024-08-01 2025-07-31 iso4217:GBP xbrli:pure

Registered number: 07426348 CELLSECO LIMITED UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 JULY 2025
CELLSECO LIMITED REGISTERED NUMBER: 07426348 BALANCE SHEET AS AT 31 JULY 2025
|  | 2025 |  | 2024
Note |  | £ |  | £
Fixed assets |  |  |  |  |
Tangible assets | 4 |  | 227 |  | 303
|  |  | 227 |  | 303
Current assets |  |  |  |  |
Debtors: amounts falling due within one year | 5 | 39,465 |  | 38,763 |
Cash at bank and in hand | 6 | 13,296 |  | 18,352 |
|  | 52,761 |  | 57,115 |
Creditors: amounts falling due within one year | 7 | (31,853) |  | (34,356) |
Net current assets |  |  | 20,908 |  | 22,759
Total assets less current liabilities |  |  | 21,135 |  | 23,062
Creditors: amounts falling due after more than one year | 8 |  | - |  | (3,437)
Net assets |  |  | 21,135 |  | 19,625
Capital and reserves |  |  |  |  |
Called up share capital |  |  | 100 |  | 100
Profit and loss account |  |  | 21,035 |  | 19,525
|  |  | 21,135 |  | 19,625
Page 1
CELLSECO LIMITED REGISTERED NUMBER: 07426348 BALANCE SHEET (CONTINUED) AS AT 31 JULY 2025 The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006. The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements. The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities. The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime. The financial statements were approved and authorised for issue by the board and were signed on its behalf on 10 February 2026.
................................................ Ido Davids
Director
The notes on pages 3 to 7 form part of these financial statements. Page 2
CELLSECO LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 JULY 2025
1. | General information
Cellseco Limited is a private company limited by shares, incorporated in England and Wales. The principal activity throughout the year was that of distribution and supply of medical and serum products, as well as the provision of business advice and mentoring. 2.Accounting policies
| 2.1 | Basis of preparation of financial statements
The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the requirements and the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view. The following principal accounting policies have been applied:
| 2.2 | Revenue
Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised: Sale of goods Revenue from the sale of goods is recognised when all of the following conditions are satisfied: ∙the Company has transferred the significant risks and rewards of ownership to the buyer; ∙the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold; ∙the amount of revenue can be measured reliably; ∙it is probable that the Company will receive the consideration due under the transaction; and ∙the costs incurred or to be incurred in respect of the transaction can be measured reliably. Rendering of services Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied: ∙the amount of revenue can be measured reliably; ∙it is probable that the Company will receive the consideration due under the contract; ∙the stage of completion of the contract at the end of the reporting period can be measured reliably; and ∙the costs incurred and the costs to complete the contract can be measured reliably.
| 2.3 | Interest income
Interest income is recognised in profit or loss using the effective interest method. Page 3
CELLSECO LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 JULY 2025 2.Accounting policies (continued)
| 2.4 | Finance costs
Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.
| 2.5 | Borrowing costs
All borrowing costs are recognised in profit or loss in the year in which they are incurred.
| 2.6 | Taxation
Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively. The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.
| 2.7 | Tangible fixed assets
Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management. Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis. Depreciation is provided on the following basis:
|  |  |  | Fixtures and fittings | - | 25% reducing balance
The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date. Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.
| 2.8 | Debtors
Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment. Page 4
CELLSECO LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 JULY 2025 2.Accounting policies (continued)
| 2.9 | Cash and cash equivalents
Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.
| 2.10 | Creditors
Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.
3. | Employees
| The average monthly number of employees, including directors, during the year was 1 (2024 - 1).
4. | Tangible fixed assets
|  | Fixtures and fittings
|  | £
| Cost or valuation |
| At 1 August 2024 | 1,380
| At 31 July 2025 | 1,380
| Depreciation |
| At 1 August 2024 | 1,077
| Charge for the year on owned assets | 76
| At 31 July 2025 | 1,153
| Net book value |
| At 31 July 2025 | 227
| At 31 July 2024 | 303
Page 5
CELLSECO LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 JULY 2025
5. | Debtors
|  |  |  |  | 2025 | 2024
|  |  |  |  | £ | £
| Trade debtors | 5,298 | 1,400
| Other debtors | 34,167 | 37,363
|  | 39,465 | 38,763
6. | Cash and cash equivalents
|  |  |  |  | 2025 | 2024
|  |  |  |  | £ | £
| Cash at bank and in hand | 13,296 | 18,352
|  | 13,296 | 18,352
7. | Creditors: Amounts falling due within one year
|  |  |  |  | 2025 | 2024
|  |  |  |  | £ | £
| Bank loans | - | 4,001
| Trade creditors | 403 | -
| Amounts owed to related companies | - | 4,386
| Corporation tax | - | 379
| Other creditors | 30,315 | 24,510
| Accruals and deferred income | 1,135 | 1,080
|  | 31,853 | 34,356
8. | Creditors: Amounts falling due after more than one year
|  |  |  |  | 2025 | 2024
|  |  |  |  | £ | £
| Bank loans | - | 3,437
|  | - | 3,437
Page 6
CELLSECO LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 JULY 2025
9. | Loans
| Analysis of the maturity of loans is given below:
|  |  |  |  | 2025 | 2024
|  |  |  |  | £ | £
| Amounts falling due within one year |  |
| Bank loans | - | 4,001
| Amounts falling due 1-2 years |  |
| Bank loans | - | 3,437
|  | - | 7,438
10. | Controlling party
The Company is controlled by the director, Ido Davids, by virtue of his shareholding, as described in the director's report.
Page 7